Indian Clinical Trial Approvals To Be Based On Risks, Innovation And Need
This article was originally published in PharmAsia News
Executive Summary
Indian drug regulatory agency listed out three key parameters for companies to secure approvals for global clinical trials. The industry sees dimming prospects for trials in India.